Delivery Order SPE2DP20D0002-SPE2DP24F1260
Award Date
12/14/23
Potential Completion Date
12/19/23
Potential Value
$305K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Teva Pharmaceuticals USA, Inc. has been awarded a $1,526,969 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. This delivery order was issued under an existing contract vehicle and will support the immunization programs of the military. Teva will deliver the vaccine products to the agency's location in Parsippany, New Jersey by December 19, 2023. As a major pharmaceutical manufacturer, Teva has extensive experience...
Teva Pharmaceuticals USA, Inc. has been awarded a $916,181 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply adenovirus type 4 vaccine. The delivery order was awarded on December 14, 2023 and is to be completed by December 19, 2023. Teva will provide the vaccine from its Parsippany, New Jersey location to support immunization programs of the Defense Logistics Agency Troop Support Medical. As the prime contractor, Teva has extensive experience...
Teva Pharmaceuticals USA, Inc. has been awarded a firm fixed price delivery order valued at one hundred fifty-two thousand six hundred ninety-six dollars and eighty-eight cents ($152,696.88) by the Defense Logistics Agency Troop Support Medical to provide adenovirus type 4 vaccine. This delivery order was issued under an existing contract vehicle and will support immunization programs of the military. Teva Pharmaceuticals USA, Inc. is a manufacturer of pharmaceutical products located in...
The U.S. Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $141,176.88 firm-fixed price delivery order for adenovirus type 4 vaccine. This order is not associated with a set-aside program. Teva Pharmaceuticals USA, Inc. is a pharmaceutical manufacturer that has provided various drug products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs to federal customers like the Department of Defense and Department of...
Teva Pharmaceuticals USA, Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical for $2,443,150.08 to supply adenovirus type 4 vaccine. The place of performance is Parsippany, New Jersey and the completion date is December 19, 2023. This delivery order supports the military immunization programs of the Defense Logistics Agency Troop Support Medical by providing the requested adenovirus type 4 vaccine. Teva Pharmaceuticals USA, Inc. is a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $317,609.46 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Teva with DLA Troop Support Medical for providing critical pharmaceuticals to support military immunization programs. Teva has also been awarded other significant...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger contract vehicle, and Teva has received multiple prior delivery orders for this vaccine to support military immunization programs. Teva also holds several significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $317,609.46 Delivery Order contract for the supply of Adenovirus Type 4 vaccines. This order falls under DLA Troop Support Medical's larger portfolio of contracts supporting military immunization programs. The contract has a firm fixed-price, with a completion date of June 25, 2024. Teva Pharmaceuticals USA, Inc. is a major supplier of critical drugs and...
Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on July 22, 2020, requires Teva Pharmaceuticals to deliver the requested pharmaceutical product to a location in Parsippany, New Jersey by July 28, 2020. No subcontractors or set aside designations were identified....
The U.S. Defense Logistics Agency Troop Support Medical awarded a $271,494.00 firm fixed price delivery order contract to Teva Pharmaceuticals USA, Inc. to provide adenovirus type 4 vaccine. Teva is a pharmaceutical manufacturer that has supplied various drug products, including vaccines, antiviral medications, and respiratory treatments, to federal agencies like the Department of Defense and Department of Veterans Affairs. This contract is not associated with a set-aside program. Teva has...